40 Million Swedish kronor to Natural Killer Cell research

Tumor stem cells hide in the body and cause patients with aggressive cancers to often relapse. By programming genetically modified killer cells to “vacuum” up the remaining tumor stem cells, it is hoped to find more effective treatment options. The international research project led by Lund University has now been awarded 40 million by Horizon Europe, to tailor immunotherapy for AML, glioblastoma and pancreatic cancer.